about
p53 Reactivation by PRIMA-1(Met) (APR-246) sensitises (V600E/K)BRAF melanoma to vemurafenib.PRIMA-1 and PRIMA-1Met (APR-246): From Mutant/Wild Type p53 Reactivation to Unexpected Mechanisms Underlying Their Potent Anti-Tumor Effect in Combinatorial Therapies.New Drug Combination Strategies in Melanoma: Current Status and Future Directions.Acquired resistance to BRAFi reverses senescence-like phenotype in mutant BRAF melanomaTargeting prohibitin with small molecules to promote melanogenesis and apoptosis in melanoma cellsKinome Profiling to Predict Sensitivity to MAPK Inhibition in Melanoma and to Provide New Insights into Intrinsic and Acquired Mechanism of Resistance Short Title: Sensitivity Prediction to MAPK Inhibitors in MelanomaThe Benefit of Reactivating p53 under MAPK Inhibition on the Efficacy of Radiotherapy in MelanomaMetabolic Reprogramming in Metastatic Melanoma with Acquired Resistance to Targeted Therapies: Integrative Metabolomic and Proteomic Analysis
P50
Q38801401-4020C3AE-E854-414C-9782-2EEA548F41C4Q47274927-21E8193C-3C55-45E0-9D54-0459F91791E2Q47881317-62E7A3B3-62F9-4BEC-82D7-61499038622EQ58796907-95713FCD-4C88-4043-A3F4-D3FFC73C4634Q89362551-632A280F-EC60-4030-B9EF-B5E00809784CQ89880128-A9672AFB-2D3F-44A9-AF9F-41EA2E3931E2Q92372745-0EE041D5-F114-4179-87D7-E8DB0131E2B0Q95829527-AE4BA988-4C35-45BD-A37B-AD3414913D1F
P50
description
investigador
@es
researcher
@en
wetenschapper
@nl
name
Ahmad Najem
@en
Ahmad Najem
@nl
type
label
Ahmad Najem
@en
Ahmad Najem
@nl
prefLabel
Ahmad Najem
@en
Ahmad Najem
@nl
P31
P496
0000-0003-0631-0029